Search

everythinglearnresearchcommunity

for

Search:↓

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Hair loss lowers young men's self-esteem, increasing social anxiety and affecting daily life.

A new gene variant in the DSP gene is linked to a unique type of hair loss.

Autologous follicular stem cells improved hair loss in 57% of patients.

Platelet-Rich Plasma (PRP) may increase hair density and thickness in Androgenetic Alopecia, but it's not significantly better than a placebo.

Higher sebum levels are linked to more severe male baldness.

No link found between hair loss severity and PSA levels in men.

AGA causes permanent hair loss; women use 2% minoxidil, men use 1 mg finasteride daily.

AGA causes permanent hair loss; minoxidil helps men, finasteride helps men, minoxidil somewhat helps women, estrogens/antiandrogens lack evidence for women.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

The guide helps clinicians diagnose and manage hair loss, detailing examination techniques and treatments for different types of alopecia.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Oral tofacitinib successfully treated total body hair loss in one patient.

Hair follicle counts and ratios are helpful in diagnosing hair loss types, but should be used with other specific features for accurate diagnosis.

Platelet-Rich Plasma therapy helps increase hair density and regrowth for some types of hair loss.

Alopecia patients in the UK want more empathy and better care from healthcare providers, including more GP training on alopecia and improved care pathways.

COVID-19 may cause hair loss, often after recovery, with androgenetic alopecia being the most common type.

Tofacitinib is effective and safe for treating alopecia areata.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

Almost 40% of older men in the study had hair loss on the front and side of their legs, and most were unaware of it.

Combining laser therapy with platelet-rich plasma improves hair growth in people with hair loss.

Hair loss in lupus patients indicates higher disease activity.